Paul Edwards Posted May 2, 2016 Share Posted May 2, 2016 "These drugs are already in clinical trials for several types of cancer, and I am excited that our work suggests they could also benefit men with prostate cancer who have otherwise run out of treatment options." At this stage it's only trials in mice. There's a long way to go through clinical trials and regulatory approval before it can be prescribed for human patients. Click on this link to read about the research conducted at the Institute of Cancer Research in London. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.